Outcomes following virological failure and predictors of switching to second-line antiretroviral therapy in a South African treatment program.
about
HIV-1 Drug Resistance Mutations: Potential Applications for Point-of-Care Genotypic Resistance TestingHigh-levels of acquired drug resistance in adult patients failing first-line antiretroviral therapy in a rural HIV treatment programme in KwaZulu-Natal, South AfricaCost-effectiveness of HIV drug resistance testing to inform switching to second line antiretroviral therapy in low income settingsModerate Levels of Pre-Treatment HIV-1 Antiretroviral Drug Resistance Detected in the First South African National SurveyImpact and programmatic implications of routine viral load monitoring in Swaziland.Predictors of immunological failure of antiretroviral therapy among HIV infected patients in Ethiopia: a matched case-control studyDelayed switch of antiretroviral therapy after virologic failure associated with elevated mortality among HIV-infected adults in Africa.Marginal Structural Models to Assess Delays in Second-Line HIV Treatment Initiation in South Africa.CD4+ and viral load outcomes of antiretroviral therapy switch strategies after virologic failure of combination antiretroviral therapy in perinatally HIV-infected youth in the United States.Sustainable HIV treatment in Africa through viral-load-informed differentiated care.Viral suppression following switch to second-line antiretroviral therapy: associations with nucleoside reverse transcriptase inhibitor resistance and subtherapeutic drug concentrations prior to switchJourney towards universal viral load monitoring in Maputo, Mozambique: many gaps, but encouraging signs.Switching to second-line ART in relation to mortality in a large Tanzanian HIV cohort.Pretreatment HIV drug resistance increases regimen switches in sub-Saharan Africa.When patients fail UNAIDS' last 90 - the "failure cascade" beyond 90-90-90 in rural Lesotho, Southern Africa: a prospective cohort study.Point-of-Care Viral Load Testing for Sub-Saharan Africa: Informing a Target Product Profile.CD4 count-based failure criteria combined with viral load monitoring may trigger worse switch decisions than viral load monitoring alone.Point-of-care diagnostics to improve maternal and neonatal health in low-resource settings.Immunological failure in HIV-infected adults from 2003 to 2015 in Southwest Ethiopia: a retrospective cohort study
P2860
Q28271593-F88E4544-7172-4688-8A82-EAEE0140D330Q28535483-6CA6FD9A-F6DA-48FB-820D-5F365524F1CAQ28543578-2C23C424-6784-4FF9-8925-40B8CD58B4A5Q28554729-60DB10CA-254F-4E92-881E-8223EB2FC8AAQ34110897-8A1F1BB0-36E7-43B1-AC48-A10E1ACAFE95Q34764695-9818D14A-191D-4CB4-B7A9-A713F361A042Q35049762-DE862F36-5A6F-4399-88B4-A353F0D847E7Q36109276-7B79DD32-0BBC-42F7-A4AE-89BE68DB2348Q36180809-8AB33019-6A65-45A5-B93E-2382BF2398FAQ37064741-0D0BBE95-964E-47DA-AFB5-047B92EA69FDQ37582314-23A4E197-F537-4E40-A58C-E6DEA994CD0DQ38556931-DED976E6-C5A4-4302-8854-51D0675A75FAQ38848107-7EE15D0A-5FFB-4914-8129-191806A7F32EQ38858252-73269086-A6DC-4F5C-9242-6306B2D97DA5Q39155386-7C39C44D-2886-42D1-8241-752581B26B73Q39353931-E62156DA-BE3C-47B5-8438-435182796992Q40301916-0C04C828-E102-43B7-A25A-998930046730Q46303043-C9E07161-44A3-47CA-8B2C-44CD6C746D05Q58769869-76897AB4-1005-4E98-8E63-E01A24849AE5
P2860
Outcomes following virological failure and predictors of switching to second-line antiretroviral therapy in a South African treatment program.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Outcomes following virological ...... uth African treatment program.
@en
Outcomes following virological ...... uth African treatment program.
@nl
type
label
Outcomes following virological ...... uth African treatment program.
@en
Outcomes following virological ...... uth African treatment program.
@nl
prefLabel
Outcomes following virological ...... uth African treatment program.
@en
Outcomes following virological ...... uth African treatment program.
@nl
P2093
P2860
P921
P1476
Outcomes following virological ...... uth African treatment program.
@en
P2093
Alison D Grant
Andrew Phillips
Gavin Churchyard
Victoria Johnston
P2860
P304
P356
10.1097/QAI.0B013E318266EE3F
P407
P577
2012-11-01T00:00:00Z